Skip to main content
. Author manuscript; available in PMC: 2012 Oct 11.
Published in final edited form as: Asia Pac J Clin Nutr. 2012;21(2):271–281.

TABLE 2.

Cardiometabolic risk factors by cluster

CVD risk factors Healthy (n= 476) High BP (n= 313) Low HDL-C (n= 654) Insulin resistant (n= 84) High CRP (n= 241)
Variables in cluster analysis
 TG, mg/dL 97.4 ± 1.9 183.5 ± 7.9 118.3 ± 2.3 187.5 ± 8.9 139.6 ± 4.2
 HDL-C, mg/dL 51.5 ± 0.4 38.9 ± 0.5 35.5 ± 0.2 39.8 ± 1.1 38.1 ± 0.6
 LDL-C, mg/dL 128.6 ± 1.5 122.1 ± 1.9 106.1 ± 1.1 123.6 ± 3.8 132.1 ± 2.4
 Systolic blood pressure, mmHg 115.2 ± 0.6 145.9 ± 1.2 107.9 ± 0.5 128.0 ± 2.2 123.6 ± 3.8
 Diastolic blood pressure, mmHg 77.5 ± 0.4 95.4 ± 0.6 72.3 ± 0.3 84.7 ± 1.3 82.5 ± 0.7
 Fasting glucose, mmol/L 4.0 ± 0.0 5.4 ± 0.1 5.0 ± 0.0 12.5 ± 0.4 5.5 ± 0.1
 CRP, mg/dL 0.9 ± 0.0 1.2 ± 0.1 0.8 ± 0.0 3.7 ± 0.3 5.5 ± 0.1
 HOMA-IR, mg/dL x μg/mL 2.1 ± 0.1 3.1 ± 0.1 2.3 ± 0.1 10.9 ± 1.0 3.9 ± 0.1
Prevalence of risk indicators, %
 Elevated TG 10.3 ± 1.4 49.2 ± 2.8 23.4 ± 1.7 69.0 ± 5.1 35.3 ± 3.1
 Low HDL-C 50.5 ± 2.3 89.1 ± 1.8 99.2 ± 0.3 84.5 ± 4.0 90.5 ± 1.9
 Elevated LDL-C 44.8 ± 2.3 38.3 ± 2.8 20.0 ± 1.6 38.1 ± 5.3 50.2 ± 3.2
 Hypertension 25.9 ± 2.0 95.8 ± 1.1 7.8 ± 1.1 51.2 ± 5.5 49.8 ± 3.2
 Elevated fasting glucose 12.6 ± 1.5 31.0 ± 2.6 13.6 ± 1.3 100.0 ± 0.0 34.4 ± 3.1
 Elevated CRP 4.2 ± 0.9 9.3 ± 1.7 4.5 ± 0.8 45.2 ± 5.5 94.6 ± 1.5
 Elevated HOMA-IR 5.7 ± 1.1 18.6 ± 2.2 8.0 ± 1.1 76.2 ± 4.7 29.0 ± 2.9
Other indicators
 Total cholesterol, mg/dL 199.7 ± 1.6 196.4 ± 2.2 165.4 ± 1.3 202.9 ± 4.3 199.1 ± 2.5
 Elevated total cholesterol, % 45.3 ± 2.3 47.3 ± 2.8 14.6 ± 1.4 50.0 ± 5.5 45.6 ± 3.2
 Fasting insulin, pmol/L 46.5 ± 1.3 64.4 ± 2.3 51.3 ± 1.3 133.2 ± 15.9 79.3 ± 2.7
 Elevated fasting insulin, % 4.6 ± 1.0 13.8 ± 2.0 6.0 ± 0.9 33.3 ± 5.2 22.4 ± 2.7

Results are means ± SE for continuous variables and percent ± SE categorical variables